Biotech Week Boston marks 10 years with 5,000-plus attendees expected

Biotech Week Boston returns to the Hynes Convention Center Sept. 22-25 with more than 5,000 attendees from 48 countries and a bigger program for its 10th anniversary. The event adds a new obesity science conference, expands manufacturing and investment tracks, and aims to connect biotech leaders across the drug-development pipeline.

Why it matters: - Biotech Week Boston has grown into a major annual gathering for the life sciences industry, spanning scientific research, manufacturing, investing and commercialization in one place. - The 2026 edition could shape dealmaking, hiring and technology adoption across biotech by bringing together executives, researchers, investors and service providers. - The addition of obesity science reflects the rapid expansion of the obesity therapeutics market.

What happened: - Biotech Week Boston 2026 will run Sept. 22-25 at the Hynes Convention Center in Boston. - The event will mark its 10-year anniversary with more than 5,000 global attendees from 48 countries. - The program now co-locates nine events under the Biotech Week Boston umbrella. - New programming includes Obesity Science & Innovation, Biotech Week Boston Campus and expanded content across manufacturing and partnering.

The details: - Obesity Science & Innovation will debut Sept. 23-24 with 150-plus experts. - Speakers for the obesity conference include leaders from Zealand Pharma, Antag Therapeutics, Aphaia Pharma, Eli Lilly, AstraZeneca and University College London. - BioProcess International adds a new CMC Strategy and Manufacturing Performance track focused on data-driven tools and manufacturing approaches. - Featured BioProcess speakers include Elisabeth Krug of Eli Lilly & Company, Jian Ren of AbbVie and Tom Gervais of Macrogenics. - BioPharm America has merged into LSX Congress USA, combining biotech CEO partnering with a global investment forum. - Biotech Week Boston Campus is aimed at early-career scientists and PhD students and offers career advice, skills building and networking. - The full lineup also includes Life Sciences Product Launch Summit, Cell & Gene Therapy International, RNA Leaders USA, Bioinnovation Group Summit and Finance & Accounting for Bioscience. - The exhibition will feature more than 250 exhibitors. - Attendees will also have access to plenary keynotes, panels and networking events. - Registration, event details and media accreditation are available through Biotech Week Boston information.

Between the lines: - The event’s expansion signals where the industry is concentrating attention: obesity, manufacturing scale-up, RNA, cell and gene therapy, and capital access. - Folding BioPharm America into LSX Congress USA suggests stronger emphasis on high-value partnering and investor conversations. - The early-career campus points to talent development as a priority for the sector. - Informa Connect is using the anniversary to position Biotech Week Boston as a single stop for discovery, investment and commercialization.

What's next: - Biotech Week Boston will open Sept. 22 and continue through Sept. 25. - Media can attend with complimentary press credentials for keynotes, panels, the exhibition floor and networking events. - Organizers are likely to use the 10th anniversary to showcase new partnerships, product launches and investment discussions across the week.

The bottom line: - Biotech Week Boston is scaling up its biggest program yet to reflect how the biotech industry now spans science, manufacturing and capital in one increasingly connected market.